Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 12

1.

Molecular evolution of antibody cross-reactivity for two subtypes of type A botulinum neurotoxin.

Garcia-Rodriguez C, Levy R, Arndt JW, Forsyth CM, Razai A, Lou J, Geren I, Stevens RC, Marks JD.

Nat Biotechnol. 2007 Jan;25(1):107-16. Epub 2006 Dec 17.

PMID:
17173035
[PubMed - indexed for MEDLINE]
2.

Deciphering antibody properties that lead to potent botulinum neurotoxin neutralization.

Marks JD.

Mov Disord. 2004 Mar;19 Suppl 8:S101-8. Review.

PMID:
15027061
[PubMed - indexed for MEDLINE]
3.

Molecular bases of protective immune responses against botulinum neurotoxin A--how antitoxin antibodies block its action.

Atassi MZ, Dolimbek BZ, Steward LE, Aoki KR.

Crit Rev Immunol. 2007;27(4):319-41. Review.

PMID:
18197812
[PubMed - indexed for MEDLINE]
4.

Epitope mapping: the first step in developing epitope-based vaccines.

Gershoni JM, Roitburd-Berman A, Siman-Tov DD, Tarnovitski Freund N, Weiss Y.

BioDrugs. 2007;21(3):145-56. Review.

PMID:
17516710
[PubMed - indexed for MEDLINE]
5.

Immune recognition of BoNTs A and B: how anti-toxin antibodies that bind to the heavy chain obstruct toxin action.

Atassi MZ.

Toxicon. 2009 Oct;54(5):600-13. doi: 10.1016/j.toxicon.2009.02.034. Epub 2009 Mar 11. Review.

PMID:
19285100
[PubMed - indexed for MEDLINE]
6.

Development and characterization of antibodies to carbohydrate antigens.

Heimburg-Molinaro J, Rittenhouse-Olson K.

Methods Mol Biol. 2009;534:341-57. doi: 10.1007/978-1-59745-022-5_24. Review.

PMID:
19277540
[PubMed - indexed for MEDLINE]
7.

Engineering antibodies by yeast display.

Boder ET, Raeeszadeh-Sarmazdeh M, Price JV.

Arch Biochem Biophys. 2012 Oct 15;526(2):99-106. doi: 10.1016/j.abb.2012.03.009. Epub 2012 Mar 19. Review.

PMID:
22450168
[PubMed - indexed for MEDLINE]
8.

[Exploring high affinity monoclonal antibodies for drug invention].

Furukawa K.

Nihon Rinsho. 2002 Mar;60(3):445-50. Review. Japanese.

PMID:
11904956
[PubMed - indexed for MEDLINE]
9.

Molecular engineering of antibodies for therapeutic and diagnostic purposes.

Ducancel F, Muller BH.

MAbs. 2012 Jul-Aug;4(4):445-57. doi: 10.4161/mabs.20776. Epub 2012 Jul 1. Review.

PMID:
22684311
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Latest technologies for the enhancement of antibody affinity.

Wark KL, Hudson PJ.

Adv Drug Deliv Rev. 2006 Aug 7;58(5-6):657-70. Epub 2006 May 22. Review.

PMID:
16828920
[PubMed - indexed for MEDLINE]
11.

Future of antibody purification.

Low D, O'Leary R, Pujar NS.

J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Mar 15;848(1):48-63. Epub 2006 Nov 28. Review.

PMID:
17134947
[PubMed - indexed for MEDLINE]
12.

Binding contracts: antibody engineering.

Geisow MJ.

Trends Biotechnol. 1991 Apr;9(4):113-5. Review. No abstract available.

PMID:
1367389
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk